Summary
Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include SNBL USA preclinical expertise, SNBL preclinical drug safety research (DSR) expertise, general toxicology, immunotoxicology and specific toxicology. SNBL also provides developmental and reproductive toxicology, carcinogenicity testing, pharmacokinetics and biodistribution, safety and efficacy models, acute radiation syndrome (ARS), safety pharmacology, blood and tissue services, and archiving among others. SNBL also conducts research and development activities. The company has its operations in the US, England, Hong Kong, Japan, China and Cambodia. SNBL is headquartered in Chuo-ku, Tokyo, Japan.
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Shin Nippon Biomedical Laboratories, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
WaVe Life Sciences Raises USD18 Million in Series A Financing 12
Partnerships 13
Shin Nippon Biomedical Labs Terminates Licensing Agreement with Besins Healthcare 13
SNBL USA Enters into Contract with BARDA 14
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 15
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 16
ISA Therapeutics Enters into R&D Agreement with Shin Nippon Biomedical Labs 17
Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University 18
Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Nihon University 19
Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Retina Institute Japan 20
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 21
Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience 22
Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University For Cerebral Infarction Treatment 23
Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 25
Licensing Agreements 26
Transcept Pharma And Shin Nippon Biomedical Labs Enter Into Licensing Agreement For Acute Migraine Treatment 26
Shin Nippon Biomedical Labs Enters Into Licensing Agreement With Pastorus Pharma 28
Equity Offering 29
Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$35.5 Million Upon Exercise Of Warrants 29
Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$38 Million Upon Exercise Of Warrants 30
Retina Institute Japan Announces Private Placement Of 300 Million Shares 31
Shin Nippon Biomedical Laboratories, Ltd. - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Shin Nippon Biomedical Laboratories, Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
Shin Nippon Biomedical Laboratories, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
WaVe Life Sciences Raises USD18 Million in Series A Financing 12
Shin Nippon Biomedical Labs Terminates Licensing Agreement with Besins Healthcare 13
SNBL USA Enters into Contract with BARDA 14
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 15
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 16
ISA Therapeutics Enters into R&D Agreement with Shin Nippon Biomedical Labs 17
Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University 18
Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Nihon University 19
Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Retina Institute Japan 20
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 21
Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience 22
Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University For Cerebral Infarction Treatment 23
Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 25
Transcept Pharma And Shin Nippon Biomedical Labs Enter Into Licensing Agreement For Acute Migraine Treatment 26
Shin Nippon Biomedical Labs Enters Into Licensing Agreement With Pastorus Pharma 28
Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$35.5 Million Upon Exercise Of Warrants 29
Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$38 Million Upon Exercise Of Warrants 30
Retina Institute Japan Announces Private Placement Of 300 Million Shares 31
Shin Nippon Biomedical Laboratories, Ltd., Key Competitors 32
Shin Nippon Biomedical Laboratories, Ltd., Key Employees 33
Shin Nippon Biomedical Laboratories, Ltd., Other Locations 34
Shin Nippon Biomedical Laboratories, Ltd., Subsidiaries 35
List of Figures
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Shin Nippon Biomedical Laboratories, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
